Indirect co-culture of lung carcinoma cells with hyperthermia-treated mesenchymal stem cells influences tumor spheroid growth in a collagen-based 3-dimensional microfluidic model

被引:29
作者
Dhiman, Nandini [1 ,2 ]
Shagaghi, Nadin [1 ]
Bhave, Mrinal [1 ]
Sumer, Huseyin [1 ]
Kingshott, Peter [1 ,3 ]
Rath, Subha Narayan [2 ]
机构
[1] Swinburne Univ Technol, Fac Sci Engn & Technol, Dept Chem & Biotechnol, Hawthorn, Vic 3122, Australia
[2] Indian Inst Technol, Dept Biomed Engn, Regenerat Med & Stem Cell Lab, Hyderabad, Medak, India
[3] Swinburne Univ Technol, Sch Engn, ARC Training Ctr Surface Engn Adv Mat, Hawthorn, Vic, Australia
关键词
mesenchymal stem cells; microfluidic cancer model; MSC-conditioned medium; lung tumor spheroids; 3D cell culture; HUMAN AMNIOTIC MEMBRANE; STROMAL CELLS; CANCER; PROLIFERATION; CULTURE; STRATEGIES; APOPTOSIS;
D O I
10.1016/j.jcyt.2020.07.004
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background: Mesenchymal stem cells (MSCs) have paradoxically been reported to exert either proor antitumor effects in vitro. Hyperthermia, in combination with chemotherapy, has tumor-inhibiting effects; however, its role, together with MSCs, so far is not well understood. Furthermore, a lot of research is conducted using conventional 2-dimensional in vitro models that do not mimic the actual tumor microenvironment. Aim: In light of this fact, an indirect method of co-culturing human amniotic membrane-derived MSCs (AMMSCs) with collagen-encapsulated human lung carcinoma cells (A549) was performed using a 3-dimensional (3D) tumor-on-chip device. Methods: The conditioned medium of AMMSCs (AMMSC-CM) or heat-treated AMMSCs (heat-AMMSC-CM) was utilized to create indirect co-culture conditions. Tumor spheroid growth characterization, immunocytochemistry and cytotoxicity assays, and anti-cancer peptide (P1) screening were performed to determine the effects of the conditioned medium. Results: The A549 cells cultured inside the 3D microfluidic chip developed into multicellular tumor spheroids over five days of culture. The AMMSC-CM, contrary to previous reports claiming its tumor-inhibiting potential, led to significant proliferation of tumor spheroids. Heat-AMMSC-CM led to reductions in both spheroid diameter and cell proliferation. The medium containing the P1 peptide was found to be the least cytotoxic to tumor spheroids in co-culture compared with the monoculture and heat-co-culture groups. Conclusions: Hyperthermia, in combination with the anticancer peptide, exhibited highest cytotoxic effects. This study highlights the growing importance of 3D microfluidic tumor models for testing stem-cell-based and other anti-cancer therapies. (C) 2020 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:25 / 36
页数:12
相关论文
共 60 条
[41]   Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance [J].
Schmidt, Felix ;
Efferth, Thomas .
PHARMACEUTICALS, 2016, 9 (02)
[42]  
Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO
[43]  
2-9
[44]  
Shagaghi N., 2017, THESIS, P1
[45]   Mesenchymal stem cells engineered for cancer therapy [J].
Shah, Khalid .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (08) :739-748
[46]   Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs [J].
Shah, Rohan M. ;
Eldridge, Daniel S. ;
Palombo, Enzo A. ;
Harding, Ian H. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 515 (1-2) :543-554
[47]   Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels [J].
Shin, Yoojin ;
Han, Sewoon ;
Jeon, Jessie S. ;
Yamamoto, Kyoko ;
Zervantonakis, Ioannis K. ;
Sudo, Ryo ;
Kamm, Roger D. ;
Chung, Seok .
NATURE PROTOCOLS, 2012, 7 (07) :1247-1259
[48]   Modelling cancer in microfluidic human organs-on-chips [J].
Sontheimer-Phelps, Alexandra ;
Hassell, Bryan A. ;
Ingber, Donald E. .
NATURE REVIEWS CANCER, 2019, 19 (02) :65-81
[49]  
STORM FK, 1979, CANCER RES, V39, P2245
[50]   Microfluidic 3D models of cancer [J].
Sung, Kyung Eun ;
Beebe, David J. .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 79-80 :68-78